Dennis F Steadman

US Patent:

20060239928, Oct 26, 2006

Filed:

Feb 17, 2006

Appl. No.:

11/356451

Inventors:

Mark Heit - Lansdale PA, US
Antonio Benitz - Portage MI, US
Dennis Steadman - Yardley PA, US
David Petrick - Princeton NJ, US

International Classification:

A61K 38/12
A61K 31/7048
A61L 9/04
A61K 31/4178
A61K 31/704

US Classification:

424045000, 514026000, 514028000, 514011000, 514731000, 514397000, 514567000

Abstract:

The invention includes compositions for transmucosal administration to an animal comprising at least one active agent and a pharmaceutically acceptable carrier. A preferred active agent is selected from the group consisting of meloxicam, carprofen, enrofloxacin, clemastine, diphenhydramine, digoxin, levothyroxine, cyclosporine, ondansetron, lysine, zolpidem, propofol, nitenpyram, ivermectin, milbemycin, and pharmaceutically acceptable salts, solvates and esters thereof. In another embodiment, the invention includes methods of treating or preventing a condition in an animal comprising transmucosally administering a composition comprising a therapeutically or prophylactically effective amount of an active agent and a pharmaceutically acceptable carrier.

US Patent:

20120289470, Nov 15, 2012

Filed:

Dec 15, 2011

Appl. No.:

13/327028

Inventors:

Mark C. HEIT - Lansdale PA, US
Antonio M. BENITZ - Portage MI, US
Dennis F. STEADMAN - Yardley PA, US
David M. PETRICK - Princeton NJ, US

International Classification:

A61K 31/5415
A61K 31/40
A61K 31/366
A61K 31/496
A61K 31/138
A61K 31/7048
A61K 31/198
A61K 38/13
A61K 31/437
A61K 31/05
A61K 31/44
A61K 47/10
A61P 29/00
A61P 33/00
A61P 37/08
A61P 9/00
A61P 37/06
A61P 3/02
A61P 25/20
A61P 1/08
A61P 31/04
A61K 31/403

US Classification:

514 205, 5142265, 514411, 514428, 514450, 51425308, 514648, 514 26, 514567, 514564, 514300, 514731, 514357, 514 30, 514772

Abstract:

The invention includes compositions for transmucosal administration to an animal comprising at least one active agent and a pharmaceutically acceptable carrier. A preferred active agent is selected from the group consisting of meloxicam, carprofen, enrofloxacin, clemastine, diphenhydramine, digoxin, levothyroxine, cyclosporine, ondansetron, lysine, zolpidem, propofol, nitenpyram, ivermectin, milbemycin, and pharmaceutically acceptable salts, solvates and esters thereof. In another embodiment, the invention includes methods of treating or preventing a condition in an animal comprising transmucosally administering a composition comprising a therapeutically or prophylactically effective amount of an active agent and a pharmaceutically acceptable carrier.

US Patent:

20150174060, Jun 25, 2015

Filed:

Dec 22, 2014

Appl. No.:

14/578728

Inventors:

- Abbott Park IL, US
Antonio M. Benitz - Portage MI, US
Dennis F. Steadman - Yardley PA, US
David M. Petrick - Princeton NJ, US

International Classification:

A61K 9/00
A61D 7/00
A61K 31/352
A61M 11/00
A61K 31/44
A61K 31/7048

Abstract:

The invention includes compositions for transmucosal administration to an animal comprising at least one active agent and a pharmaceutically acceptable carrier. A preferred active agent is selected from the group consisting of meloxicam, carprofen, enrofloxacin, clemastine, diphenhydramine, digoxin, levothyroxine, cyclosporine, ondansetron, lysine, zolpidem, propofol, nitenpyram, ivermectin, milbemycin, and pharmaceutically acceptable salts, solvates and esters thereof. In another embodiment, the invention includes methods of treating or preventing a condition in an animal comprising transmucosally administering a composition comprising a therapeutically or prophylactically effective amount of an active agent and a pharmaceutically acceptable carrier.